{"id":"W4414927188","doi":"10.1007/s13555-025-01557-1","title":"Bimekizumab Efficacy in Psoriasis by Subgroups: Post Hoc Analysis of Phase 3/3b Clinical Trials","year":2025,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dermatrials Research","funders":"Manchester Biomedical Research Centre; Allergan; LEO Pharma; National Institute for Health and Care Research; Incyte; Sun Pharma; Regeneron Pharmaceuticals; UCB; Celgene; Biogen; Valeant Pharmaceuticals International; Sanofi; Amgen; Meiji Seika Pharma; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Clinical trial; Post-hoc analysis; Psoriasis; Post hoc; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06792486,0.003062224,0.009644937,0.001678378,0.0005077588,0.002805015,0.001856076,0.001799522,0.005926365],"category_scores_gemma":[0.0514835,0.001037334,0.02052002,0.002075979,0.001212919,0.002787945,0.002086112,0.004607177,0.0006481453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001150285,"about_ca_system_score_gemma":0.002232442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007695947,"about_ca_topic_score_gemma":0.00112608,"domain_scores_codex":[0.9261044,0.05828452,0.004488828,0.00523864,0.003439072,0.002444471],"domain_scores_gemma":[0.9317414,0.0492551,0.007080666,0.00813251,0.002550637,0.001239671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.764815,0.001133535,0.01521625,0.00407078,0.1799405,0.0002693376,0.0002919731,0.005942518,0.004832461,0.0004231914,0.005648418,0.01741606],"study_design_scores_gemma":[0.2987739,0.1615879,0.179927,0.001166547,0.2791408,0.0009734622,0.0007656348,0.03802709,0.009827599,0.006008143,0.02319603,0.0006059677],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9137815,0.02956457,0.01704408,0.001095665,0.001929106,0.01167959,0.01737522,0.0008299829,0.006700363],"genre_scores_gemma":[0.9612246,0.002253719,0.008620906,0.001244965,0.0005267985,0.01504388,0.007789951,0.0005843249,0.002710938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06792486,"threshold_uncertainty_score":0.3592253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04833259873561692,"score_gpt":0.3833636814334019,"score_spread":0.335031082697785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}